Platelet-rich plasma (PRP), commonly referred to as “growth factor”, is a group of proteins found in our blood, but in low concentrations.
Upon permeating an area of the body, these proteins begin to stimulate the already present cells, triggering a process of regeneration and new tissue formation. The result is an improved, faster recovery from muscle, tendon, bone, and cartilage injuries, etc.
The plasma enriched with growth factor is obtained via a simple extraction of 20-40 ml of the patient´s own blood. Once extracted, the blood is processed by an automated system that increases the concentration of growth factor in the plasma.
The portion of plasma rich in growth factor is then identified and the remainder is discarded. The plasma enriched with growth factor is now ready to be injected directly into the affected area.
The use of PRP allows for the pain of injuries to be reduced and the speed of their healing to be accelerated, thus decreasing patients´ functional rehabilitation to less than half of the expected duration.
The treatment acts as a complement to surgery. As such, it requires no form of additional care.
No. By treating with proteins and biostimulants obtained from the blood of the same patient, there is no possibility of rejection.
No. Corticosteroids reduce inflammation by blocking the inflammation process, thus reducing the arrival of blood in the treated area. PRPs are proteins that stimulate healing, contributing to the flow of scar cells.
An optional post-operative treatment, PRP therapy enables for recovery times to be reduced by aiding a quicker healing process.Curriculum